Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 1 February 2007, Vol. 109, No. 3, pp. 1237-1240.
Prepublished online as a Blood First Edition Paper on September 28, 2006; DOI 10.1182/blood-2006-07-037465.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-07-037465v1
109/3/1237    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walter, M. J.
Right arrow Articles by Ley, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walter, M. J.
Right arrow Articles by Ley, T. J.
Related Collections
Right arrow Neoplasia
Right arrow Oncogenes and Tumor Suppressors
Right arrow Brief Reports
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

NEOPLASIA

Brief Report

Expression of a bcr-1 isoform of RAR{alpha}-PML does not affect the penetrance of acute promyelocytic leukemia or the acquisition of an interstitial deletion on mouse chromosome 2

Matthew J. Walter1,2,3, Rhonda E. Ries1,2, Jon R. Armstrong4, John S. Park1,2, Elaine R. Mardis4, and Timothy J. Ley1,2,3

1 Department of Medicine, 2 Division of Oncology, 3 Siteman Cancer Center, and 4 Genome Sequencing Center, Washington University School of Medicine, St Louis, MO

Expression of a bcr-3 isoform of retinoic acid receptor {alpha}–promyelocytic leukemia (RAR{alpha}-PML) in mice expressing a bcr-1 isoform of PML-RAR{alpha} is associated with increased penetrance of murine acute promyelocytic leukemia (APL) and the frequent acquisition of an interstitial deletion of one copy of mouse chromosome 2 (del(2)). To determine whether the isoform of RAR{alpha}-PML is important for these effects, we created mice that expressed a bcr-1 isoform of RAR{alpha}-PML. Coexpression with the bcr-1 isoform of PML-RAR{alpha} did not increase the penetrance of APL (7 of 45 animals developed APL with PML-RAR{alpha} alone vs 12 of 44 with both transgenes; P = .19). Furthermore, the frequency of del(2) in APL cells from doubly transgenic mice was not different from that of mice expressing PML-RAR{alpha} alone (3 of 6 vs 6 of 12, respectively—P = 1.38—compared with 11 of 11 for mice coexpressing PML-RAR{alpha} and bcr-3 RAR{alpha}-PML). The bcr-1 and bcr-3 isoforms of RAR{alpha}-PML, therefore, have different biological activities that may be relevant for the pathogenesis of murine APL.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 haematolHome page
T. Kondo, A. Mori, S. Darmanin, S. Hashino, J. Tanaka, and M. Asaka
The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia
Haematologica, September 1, 2008; 93(9): 1414 - 1416.
[Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020